3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
4
Carcinoma, Renal Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Kidney Neoplasms
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia
2
Warts
1
Small Cell Lung Carcinoma
1
Recurrence
1
Papilloma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lung Neoplasms
1
HIV Infections
1
Colorectal Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Everolimus
16
Octreotide
6
pembrolizumab
5
lanreotide
5
Sunitinib
5
Magnetic Resonance Spectroscopy
5
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
lenvatinib
3
arginyllysine
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
pasireotide
2
lutetium Lu 177 dotatate
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Temozolomide
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroendocrine Tumors
×
Interferon-alpha
×
Clear all
No trials found.